1. Home
  2. PICS vs XERS Comparison

PICS vs XERS Comparison

Compare PICS & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PicS N.V. Class A Common Shares

PICS

PicS N.V. Class A Common Shares

N/A

Current Price

$13.69

Market Cap

1.4B

Sector

Finance

ML Signal

N/A

XERS

Xeris Biopharma Holdings Inc.

N/A

Current Price

$10.50

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PICS
XERS
Founded
2012
2005
Country
Brazil
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
PICS
XERS
Price
$13.69
$10.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
7
Target Price
★ $19.61
$12.86
AVG Volume (30 Days)
490.5K
★ 2.3M
Earning Date
08-24-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 100.00
EPS
★ N/A
N/A
Revenue
N/A
★ $49,590,000.00
Revenue This Year
$48.94
$32.91
Revenue Next Year
$38.31
$23.75
P/E Ratio
$29.44
★ N/A
Revenue Growth
N/A
★ 142.67
52 Week Low
$8.11
$5.25
52 Week High
$18.49
$10.35

Technical Indicators

Market Signals
Indicator
PICS
XERS
Relative Strength Index (RSI) 72.20 70.31
Support Level $13.20 $7.15
Resistance Level $13.78 N/A
Average True Range (ATR) 0.75 0.53
MACD 0.55 0.13
Stochastic Oscillator 98.32 96.50

Price Performance

Historical Comparison
PICS
XERS

About PICS PicS N.V. Class A Common Shares

PicS NV is a digital payments company. The company operates a peer-to-peer (P2P) transfer platform that enables individuals to send money via mobile devices. It provides digital wallets, instant payments (Pix), P2P transfers, credit cards, loans, investments, insurance, and SMB payment solutions. The company has four reportable segments: Consumer Banking, Small and Medium-Sized Businesses, Audiences and Ecosystem Integration, and Institutional. The majority of the company's revenue is derived from the Consumer Banking segment, which generates revenue from various transaction activities occurring in the digital wallet, such as Pix, peer-to-peer (P2P) transfers, and bill payments.

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.

Share on Social Networks: